74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Enzo Biochem Inc
Closed
Sector Healthcare
0.51
Overview
Share price change
24h
Min
0.51
Max
0.51
Income | 10M -3.4M |
|---|---|
Sales | -1.3M 6.2M |
EPS | -0.065 |
Dividend yield | 79.74 |
Profit margin | -54.338 |
Employees | 125 |
EBITDA | -683K -2.8M |
Dividend yield Sector Avg | 79.74% 3.09% |
|---|---|
Next Earnings | 11 Mar 2025 |
Market Cap | -34M 27M |
|---|---|
Previous open | 0.51 |
Previous close | 0.51 |
News Sentiment
By Acuity
50%
50%
157 / 393 Healthcare
Enzo Biochem Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Enzo Biochem Inc Forecast
Sentiment
By Acuity
157 / 393 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Enzo Biochem Inc
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.
